Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

N/AApproved For MarketingNCT02577562

Cook Group Incorporated

Overview

The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

Study Type

EXPANDED_ACCESS

Conditions

Abdominal Aortic Aneurysms Aorto-iliac Aneurysms Juxtarenal Aneurysms

Interventions

Zenith® Fenestrated AAA Endovascular GraftDEVICE

The Zenith® Fenestrated AAA Endovascular Graft with the H\&L-B One-Shot™ Introduction System is indicated for the endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms having morphology suitable for endovascular repair

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Abdominal aortic and aortoiliac aneurysms with diameter greater than or equal to 5 cm Exclusion Criteria: * Proximal neck less than 4 mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal * Renal artery stenosis greater than 50 percent

Locations (15)

University of California, San Francisco

San Francisco, California, United States

Shands Hospital

Gainesville, Florida, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.